Newsfeed : AbbVie Does Not Appeal 9th Circuit Heightened Scrutiny Ruling

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Newsfeed » March 2014

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


March 11, 2014

AbbVie Does Not Appeal 9th Circuit Heightened Scrutiny Ruling

A ruling by a federal appeals court on juror selection will stand, Reuters reports. AbbVie, a pharmaceutical company involved in the case, will not appeal the ruling to the U.S. Supreme Court.

A unanimous decision by the 9th U.S. Circuit Court of Appeals, which is headquartered in San Francisco, ruled that as a result of a potential juror being wrongly removed because he is gay that a new trial was warranted. There will be no appeal by AbbVie of the decision about the juror, but the company has not yet decided if it will appeal the decision for a new trial.

The 9th Circuit ruled that discrimination based on sexual orientation is subject to heightened scrutiny, which means courts consider equal protection claims more carefully. They based their ruling on a U.S. Supreme Court decision to strike down a portion of the Defense of Marriage Act. As a result, a Supreme Court case barring juror strikes based on race now also covers sexual orientation.

In 2007, Abbott Laboratories raised the price of the HIV drug Norvir by 400 percent. GlaxoSmithKline (GSK) soon after filed an antitrust lawsuit against Abbott claiming the high price prevented the booster from being used with other drugs. In 2011, a jury ruled mostly in favor of Abbott, saying the company did not hike the price out of malice.

GSK appealed using as one of its arguments for a new trial that an Abbott lawyer had a man who identified himself as gay removed from the jury pool because of his sexual orientation. Abbott claims it removed the man for several other reasons, including that he had a friend who died of AIDS-related complications.

Lawyers in both sides of trials are allowed to remove potential jurors without legal justification. However, the U.S. Supreme Court has ruled that race and gender cannot be used as reasons to remove potential jurors. If a new trial for GSK proceeds, it would be against Abbott spinoff AbbVie.

To read the article, click here.

Search: GSK, Abbott, AbbVie, antitrust, Norvir

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.